The Rovati family, which has owned the research center Rottapharm since 2014, announced the intention to divest the laboratories. At the same time, it informed the...
After its approval in the US for COVID-19 treatment, the demand for remdesivir could explode. Gilead's decision to donate its entire stockpile to the US government...
Various organizations in different countries are seeking solutions that can prevent or combat the new coronavirus and prevent its expansion. A team of scientists and businessmen...
The biotech company Seqens announced that it is prepared to begin large scale production of hydroxychloroquine. According to the company, the needs for this treatment could...
Sartorius has just completed the acquisition of selected life science businesses from Danaher Corporation, for which it paid $825 million. With the acquisition of Danaher, Sartorius...
Walloon companies have shown reactivity in the corona crisis, thanks to the structuring of the biopharma ecosystem and medical equipment. A sector that could take advantage...
With the $12 million (€11 million) financing, Bone Therapeutics will be able to continue its activities until the first quarter of 2021. Once markets return to...
Ivermectin is being researched to evaluate its efficacy in the treatment of COVID-19. In the event of positive results, MedinCell may position a long-acting version of...
The Lyon-based biotech company Genoway closed 2019 on a mixed note, but nevertheless recorded the first fruits of its strategy, which is now focused on the...
Last month, NG Biotech announced the launch of a serological test to find if a person was infected with COVID-19. The latest announcements of developments of...